Journal Article


Suranga L Senanayake


Medicine & Nursing

humans global broad spectrum antiviral agents drug repurposing phase covid 19 clinical

Drug repurposing strategies for COVID-19 (2020)

Abstract COVID-19 has now been declared a pandemic and new treatments are urgently needed as we enter a phase beyond containment. Developing new drugs from scratch is a lengthy process, thus impractical to face the immediate global challenge. Drug repurposing is an emerging strategy where existing medicines, having already been tested safe in humans, are redeployed to combat difficult-to-treat diseases. While using such repurposed drugs individually may ultimately not yield a significant clinical benefit, carefully combined cocktails could be very effective, as was for HIV in the 1990s; the urgent question now being which combination.
Collections Ireland -> University of Limerick -> Graduate Entry Medical School
Ireland -> University of Limerick -> Faculty of Education & Health Sciences
Ireland -> University of Limerick -> Departments Education & Health Sciences

Full list of authors on original publication

Suranga L Senanayake

Experts in our system

Suranga L Senanayake
University of Limerick
Total Publications: 3